Misha Siddiqui[1,*] Azam Hamidinekoo[3] Jennifer Y Tan[4] Renata Leke[5] Bader Zarrouki[5] Nick Trahearn[6] Yeman Brhane Hagos[4] Chirine Sakr[6] Andrea Lampis[6] Christopher Bagnall[2] Giovanni Pellegrini[7] Simon P Castillo[8] Benjamin Challis[9] Yinyin Yuan[8] Marco Bezzi[1] Stephanie Ling[2]
[*] Correspondence: misha.siddiqui@astrazeneca.com [1]{Molecular Pathology, The Institute of Cancer Research (ICR), London, UK} [2]{Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK} [3]{Image Analysis and Platform, Pathology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK} [4]{Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK} [5]{Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden} [6]{Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK} [7]{ Aptuit (Verona) Srl, an Evotec Company, Campus Levi Montalcini, Verona, Italy Aptuit (Verona) Srl, an Evotec Company, Campus Levi Montalcini, Verona, Italy} [8]{Department of Translational Molecular Pathology & Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Texas 77030, USA} [9]{Translational Science & Experimental Medicine Research and Early Development, Cardiovascular , Renal & Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK}